Medinice expects its latest PacePress® model to be approved for the European market in 2025
September 1, 2025
In an interview with Bankier.pl, Medinice’s CEO, Sanjeev Choudhary, said that the company had completed the clinical study of the PacePress® device, and the final report confirmed its effectiveness and safety. The documentation for the notified body is currently being prepared, which paves the way for obtaining CE-MDR certification still in 2025.
Sanjeev Choudhary also noted that Medinice is holding talks with potential partners regarding the commercialization of PacePress®. The company is exploring different collaboration models, from global licensing agreements to licenses divided by region, such as Europe and Asia. At the same time, opportunities for entering the US market are being analyzed.
Medinice is consistently implementing its development strategy, which aims not only to bring innovative solutions to market but also to secure stable revenue sources from their commercialization.
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.